Mega Genomics Ltd, 6667:HKG.HZ profile

Price (HKD)9.58
Today's Change-0.01 / -0.10%
Shares traded205.40k
1 Year change-12.75%
Beta--

Data delayed at least 15 minutes, as of Jul 26 2024 08:47 BST.

More ▼

Add to Your Portfolio

Name

Currency

Profile data is unavailable for this security.

About the company

Mega Genomics Ltd is a China-based investment holding company principally engaged in genetic testing business. The Company operates its businesses through three segments. The Consumer Genetic Testing Services segment provides testing for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing. The Cancer Screening Services segment provides Septin9 colorectal cancer screening test, Syndecan-2 (SDC2) colorectal cancer screening test and ring finger protein 180 (RNF180)/Septin9 gastric cancer screening test. The Other Services segment provides genetic research and analysis services to third party research institutions.

Revenue in HKD (TTM)163.34m
Net income in HKD32.43m
Incorporated2021
Employees229.00

Location
Mega Genomics Ltd401 Health WorkNorth Garden Road, Haidian DistrictBEIJING ChinaCHN
Websitehttps://www.megagenomics.cn/

More ▼

Income statement (CNY)

Year on year Mega Genomics Ltd grew revenues 3.82% from 145.73m to 151.30m. In addition the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as a percent of sales). The company reported positive net income, improving from a loss of 17.62m to a profit of 30.04m.

Explore our tools

Growth CalculatorBETA
Explore the time value of money, the impact of regular contributions, and the power of saving over longer timeframes
Alerts
Create detailed alerts and get notified the moment an event happens
Watchlists
Monitor a select list of assets
Are you sure you want to cancel?
Portfolio
See how trades would have performed from years past or start from the present
Data archive
Download PDF copies of reports from the newspaper markets data page
World markets
View the performance of global markets and browse news items by region
Equities screener
Find companies based on country, sector, and other equity characteristics
Funds overview
View funds that move the market, screen for funds and read relevant news

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Mega Genomics Ltd

Select symbol

Mega Genomics Ltd

ApplyActions

Your alerts

About the company